INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$4.9M

$4,883,228

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $778,812x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$778,812x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-03-04 $745,984x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-03-04	$745,984x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-03 $567,546x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-03	$567,546x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-03-02 $562,585x10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-03-02	$562,585x10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-02-27 $1,533,100Largex5 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-02-27	$1,533,100Largex5	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-02-13 $695,201 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-02-13	$695,201	S	Form 4